* agilon health inc AGL.N reported a quarterly adjusted
loss
of 8 cents per share for the quarter ended in September, lower
than the same quarter last year, when the company reported EPS
of -7 cents. The mean expectation of sixteen analysts for the
quarter was for a loss of 6 cents per share. Wall Street
expected results to range from -8 cents to -2 cents per share.
* Revenue rose 75% to $1.22 billion from a year ago;
analysts
expected $1.14 billion.
* agilon health inc's reported EPS for the quarter was a
loss of 8
cents.
* The company reported a quarterly loss of $31.44 million.
* agilon health inc shares had fallen by 5.0% this
quarter and
gained 4.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 26.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for agilon
health inc
is $28.00
This summary was machine generated from LSEG data November 2 at
09:02 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.06 -0.08 Missed
Jun. 30 2023 -0.03 -0.04 Missed
Mar. 31 2023 0.02 0.04 Beat
Dec. 31 2022 -0.09 -0.14 Missed